PL2629794T3 - Szczepionka wektorowa z herpeswirusem indyków przeciwko grypie ptaków u drobiu - Google Patents

Szczepionka wektorowa z herpeswirusem indyków przeciwko grypie ptaków u drobiu

Info

Publication number
PL2629794T3
PL2629794T3 PL11771123T PL11771123T PL2629794T3 PL 2629794 T3 PL2629794 T3 PL 2629794T3 PL 11771123 T PL11771123 T PL 11771123T PL 11771123 T PL11771123 T PL 11771123T PL 2629794 T3 PL2629794 T3 PL 2629794T3
Authority
PL
Poland
Prior art keywords
turkeys
herpesvirus
poultry
avian influenza
vaccine against
Prior art date
Application number
PL11771123T
Other languages
English (en)
Inventor
Paulus Jacobus Antonius Sondermeijer
Iwan Verstegen
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of PL2629794T3 publication Critical patent/PL2629794T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/869—Herpesviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PL11771123T 2010-10-18 2011-10-17 Szczepionka wektorowa z herpeswirusem indyków przeciwko grypie ptaków u drobiu PL2629794T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP10187948 2010-10-18
US40772410P 2010-10-28 2010-10-28
EP11771123.4A EP2629794B1 (en) 2010-10-18 2011-10-17 Herpesvirus of turkeys vectored vaccine against avian influenza in poultry
PCT/EP2011/068073 WO2012052384A1 (en) 2010-10-18 2011-10-17 Herpesvirus of turkeys vectored vaccine against avian influenza in poultry

Publications (1)

Publication Number Publication Date
PL2629794T3 true PL2629794T3 (pl) 2017-10-31

Family

ID=43587599

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11771123T PL2629794T3 (pl) 2010-10-18 2011-10-17 Szczepionka wektorowa z herpeswirusem indyków przeciwko grypie ptaków u drobiu

Country Status (8)

Country Link
US (1) US8986987B2 (pl)
EP (1) EP2629794B1 (pl)
CN (1) CN103370079B (pl)
ES (1) ES2635019T3 (pl)
HU (1) HUE033739T2 (pl)
MX (1) MX344069B (pl)
PL (1) PL2629794T3 (pl)
WO (1) WO2012052384A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103667351B (zh) * 2012-09-10 2017-01-25 中国农业科学院哈尔滨兽医研究所 以鸭病毒性肠炎病毒疫苗株为载体的重组病毒疫苗在鸡形目禽类中的应用
US10398769B2 (en) 2013-08-06 2019-09-03 The Trustees Of The University Of Pennsylvania Influenza nucleic acid molecules and vaccines made therefrom
CN106031793B (zh) * 2015-03-13 2020-12-01 普莱柯生物工程股份有限公司 一种活疫苗及其制备方法和应用
HK1257191A1 (zh) * 2015-08-10 2019-10-18 The Texas A&M University System 重组火鸡疱疹病毒疫苗及其用途
US11596687B2 (en) 2016-06-17 2023-03-07 Intervet Inc. Recombinant non-pathogenic Marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens
JOP20190088A1 (ar) * 2016-10-21 2019-04-21 Us Agriculture نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
CN106399267A (zh) * 2016-10-28 2017-02-15 扬州大学 表达H7N9亚型禽流感病毒血凝素蛋白的重组火鸡疱疹病毒株rHOH及构建方法
CN106497893A (zh) * 2016-10-28 2017-03-15 扬州大学 表达H7N9亚型禽流感病毒嵌合型血凝素蛋白的重组火鸡疱疹病毒株rHMW及构建方法
CN107296956A (zh) * 2017-06-29 2017-10-27 青岛易邦生物工程有限公司 一种基因重组活载体疫苗
CN109666656A (zh) * 2019-01-23 2019-04-23 北京市农林科学院 一种纯化重组鸡传染性法氏囊病毒vp2基因的马立克氏病病毒cvi988株的方法
CN110205308A (zh) * 2019-05-24 2019-09-06 华南农业大学 一种表达ha基因的重组火鸡疱疹病毒及其应用
CN114828882A (zh) 2019-12-20 2022-07-29 英特维特国际股份有限公司 多价hvt载体疫苗
CA3190070A1 (en) 2020-09-07 2022-03-10 Martijn Alexander LANGEREIS Ha stem vaccine for ha antibody-positive targets
CN116648259A (zh) 2020-12-24 2023-08-25 英特维特国际股份有限公司 多价hvt载体疫苗
CN117881422A (zh) 2021-07-13 2024-04-12 英特维特国际股份有限公司 克服禽类中的抗体干扰
US20250352642A1 (en) 2022-05-05 2025-11-20 Intervet Inc. New multivalent hvt vector vaccine

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928648A (en) * 1985-09-06 1999-07-27 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US5961982A (en) * 1985-09-06 1999-10-05 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
DE122007000004I1 (de) 1986-01-27 2007-05-24 Schering Plough Ltd Attenuierte Herpesviren, Herpesviren die eine Aminosäuresequenz kodierende fremde DNA enthalten, unddiese enthaltende Impfstoffe
US5731188A (en) * 1986-11-20 1998-03-24 Syntro Corporation Recombinant equine herpesviruses
DK0382271T3 (da) 1989-02-04 1995-05-01 Akzo Nobel Nv Tocoler som adjuvanser i vacciner
US5919461A (en) * 1989-10-18 1999-07-06 Akzo Nobel N.V. Nonpathogenic infectious bursal disease virus and vaccine
EP0431668B1 (en) 1989-12-04 1995-02-15 Akzo Nobel N.V. Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
ZA923041B (en) * 1991-05-14 1993-04-28 Akzo Nv Recombinant vaccine against marek's disease
US5690939A (en) * 1991-05-14 1997-11-25 Akzo Nobel N.V. Recombinant vaccine against marek's disease
US6183753B1 (en) * 1994-08-09 2001-02-06 Schering-Plough Veterinary Corp. Recombinant chimeric virus and uses thereof
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US6913751B2 (en) * 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US5741696A (en) * 1992-08-07 1998-04-21 Syntro Corporation Recombinant equine herpesviruses
US6875856B2 (en) * 1993-09-24 2005-04-05 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
ES2253746T3 (es) 1995-07-03 2006-06-01 Akzo Nobel N.V. Vacuna contra la coccidiosis aviar.
EP0837929A2 (en) * 1995-07-07 1998-04-29 Nippon Zeon Co., Ltd. Marek's disease virus genes and their use in vaccines for protection against marek's disease
EP0794259B1 (en) 1996-03-04 2004-10-06 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for producing a saccharide composition containing trehalulose.
AU758604B2 (en) * 1998-07-31 2003-03-27 Intervet International B.V. Attenuated equine herpesvirus
TR200101817T2 (tr) 1998-12-21 2001-12-21 Akzo Nobel N.V. Etkisizleştirilmiş S/Y emülsiyonu katkılı aşılar üretmek için yöntem
US6299882B1 (en) * 1999-04-09 2001-10-09 Schering Corporation UL54.5 of Marek's disease virus (MDV)
AU6698900A (en) 1999-07-16 2001-02-05 Agricultural Research Service Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector
US7314715B2 (en) * 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
JP2009512421A (ja) 2005-08-15 2009-03-26 ヴァクシン インコーポレイテッド 非複製性ベクターワクチン投与による鳥類への免疫方法
US20080241188A1 (en) 2007-03-30 2008-10-02 Zeon Corporation Turkey herpesvirus vectored recombinant containing avian influenza genes
BRPI0913216A2 (pt) 2008-06-23 2016-01-19 Intervet Int Bv uso de um herpesvírus recombinante de perus, e, herpesvírus recombinante de perus.
RU2559527C2 (ru) * 2008-11-28 2015-08-10 Мериал Лимитед Рекомбинантная вакцина от птичьего гриппа и её применение
WO2010119112A1 (en) 2009-04-15 2010-10-21 Ceva Sante Animale Recombinant avian herpes virus vectors and vaccine for immunizing waterfowl species

Also Published As

Publication number Publication date
EP2629794A1 (en) 2013-08-28
WO2012052384A1 (en) 2012-04-26
US8986987B2 (en) 2015-03-24
MX344069B (es) 2016-12-02
CN103370079B (zh) 2016-08-10
CN103370079A (zh) 2013-10-23
HUE033739T2 (en) 2018-01-29
EP2629794B1 (en) 2017-06-07
US20130230556A1 (en) 2013-09-05
MX2013004303A (es) 2013-05-30
ES2635019T3 (es) 2017-10-02

Similar Documents

Publication Publication Date Title
PL2629794T3 (pl) Szczepionka wektorowa z herpeswirusem indyków przeciwko grypie ptaków u drobiu
IL261204A (en) Influenza virus vaccines and their use
ZA201404797B (en) Influenza virus vaccines and uses thereof
SG11201400743VA (en) Influenza virus vaccines and uses thereof
PL2611460T3 (pl) Szczepionki przeciw herpeswirusom przenoszone z pomocą wirusa choroby newcastle
EP2552479A4 (en) INFLUENZA VIRUS VACCINES AND USES THEREOF
IL239284A0 (en) Nasal flu vaccine compound
PL3073959T3 (pl) Zespól szczepiący do podawania szczepionki do młodej kury
ZA201406979B (en) Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
SG11201401998VA (en) Vaccines directed against human enteroviruses
IL240504A0 (en) Combined vaccine for respiratory syncytial virus and influenza
ZA201300395B (en) Influenza vaccine
SG11201404147YA (en) Computationally optimized broadly reactive antigens for human and avian h5n1 influenza
IL236270B (en) Cationic lipid vaccine compositions and methods of use
PL2575872T3 (pl) Zatężanie antygenów szczepionkowych grypy bez liofilizacji
PT2874656T (pt) Vacinas atenuadas contra a gripe suína e métodos de fabricação e uso das mesmas
EP2678361A4 (en) COMPOSITIONS WITH IMPROVED IMMUNOGENICITY AND / OR REDUCED REACTIVITY AND METHOD OF USE THEREOF
EP2839840A4 (en) RECOMBINANT TRUMPLANT VACCINE AGAINST HUMAN FLUID
PL3415643T3 (pl) Wytwarzanie żywych szczepionek
ZA201307570B (en) Use of dithine-tetracarboximides as bird repellent
GB201003332D0 (en) Efficient preparation of combination vaccines
HK1197804A (en) Herpes virus vaccine and methods of use
GB201005518D0 (en) Preservation of alum-adjuvanted vaccines